Document And Entity Information
Document And Entity Information | Oct. 29, 2021 |
Cover [Abstract] | |
Document Type | 8-K/A |
Amendment Flag | true |
Document Period End Date | Oct. 29, 2021 |
Entity Registrant Name | SQZ BIOTECHNOLOGIES COMPANY |
Entity Central Index Key | 0001604477 |
Entity Emerging Growth Company | true |
Entity File Number | 001-39662 |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 46-2431115 |
Entity Address, Address Line One | 200 Arsenal Yards Blvd |
Entity Address, Address Line Two | Suite 210 |
Entity Address, City or Town | Watertown |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02472 |
City Area Code | 617 |
Local Phone Number | 758-8672 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Ex Transition Period | false |
Title of 12(b) Security | Common Stock, $0.001 par value per share |
Trading Symbol | SQZ |
Security Exchange Name | NYSE |
Amendment Description | In accordance with Instruction No. 2 to Item 5.02 of Form 8-K, this Current Report on Form 8-K/A (the “Amendment Filing”) updates the disclosures made in the Current Report on Form 8-K filed by SQZ Biotechnologies Company (the “Company”) on November 4, 2021 (the “Original Filing”) as set forth below. Except as expressly set forth herein, this Amendment Filing does not amend, modify or update the disclosures contained in the Original Filing.Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |